During the past decade, Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 11 clinical trials were completed, i.e. on average, 84.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia" are "Breast Cancer" (10 trials), "Colorectal Cancer" (2 trials), "Urothelial Carcinoma" (2 trials), "Breast Neoplasms" (1 trials) and "Carcinoma, Hepatocellular" (1 trials). Many other conditions were trialed in "Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia" are "Drug" (21 trials), "Other" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Placebo" (7 trials), "Trastuzumab" (5 trials), "Bevacizumab" (4 trials) and "Pertuzumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia" are 21 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".